Top Markets
Coin of the day
PRF Technologies Ltd. PRF Technologies Ltd.

PRF Technologies Ltd.

PRFX
Rangering i aksjer #40770
PRF Technologies Ltd. operates as a specialized pharmaceutical company,... PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Aksjekurs
$1.09
Markedsverdi
$87.38K
Endring (1 dag)
5.34%
Endring (1 år)
-85.03%
Land
IL
Handel PRF Technologies Ltd. (PRFX)

Kategori

EPS for PRF Technologies Ltd. (PRFX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til PRF Technologies Ltd. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for PRF Technologies Ltd. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter